Grovepoint Capital

Grovepoint Capital
Industry	Private equity
Founded	2010
Founder	Leon Blitz; Bradley Fried
Headquarters	London, NW1; United Kingdom
Website	grovepoint.co.uk

Grovepoint Capital is a private equity firm headquartered in London, United Kingdom.[1] It has additional offices in Israel.[1] It was co-founded by Leon Blitz and Bradley Fried in 2010.[1][2][3] In 2013, it acquired Algatechnologies, an Israeli biotech start-up, for $15 million-$20 million.[3]

References

"Company Overview of Grovepoint Capital LLP". Bloomberg Business. Retrieved October 16, 2015.
Denham, Annabelle (November 18, 2013). "Startup springboks who let the idea come to them". City A.M. Retrieved October 16, 2015.
Bar-Eli, Avi (February 10, 2013). "U.K. Investment Firm Snaps Up Israeli Start-up Algatechnologies: Grovepoint Capital is paying an estimated $15 million to $20 million for the company, which fights the effects of aging". Haaretz. Retrieved October 16, 2015.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[bloomberg-1] "Company Overview of Grovepoint Capital LLP". Bloomberg Business. Retrieved October 16, 2015.

[startupspring-2] Denham, Annabelle (November 18, 2013). "Startup springboks who let the idea come to them". City A.M. Retrieved October 16, 2015.

[ukinvest-3] Bar-Eli, Avi (February 10, 2013). "U.K. Investment Firm Snaps Up Israeli Start-up Algatechnologies: Grovepoint Capital is paying an estimated $15 million to $20 million for the company, which fights the effects of aging". Haaretz. Retrieved October 16, 2015.